Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Pemetrexed × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 167 Lung Neoplasms 61 Neoplasms 21 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Mesothelioma, Malignant 12 Colorectal Neoplasms 10 Carcinoma 10 Meningeal Carcinomatosis 9 Mesothelioma 6 Melanoma 6 Brain Neoplasms 6 NSCLC 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Advanced Solid Tumors 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Respiratory Tract Neoplasms 3 Rectal Neoplasms 3 Neoplasms by Histologic Type 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Bronchial Neoplasms 3

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡